ERAS - Erasca, Inc. -  [ ]

Ticker Details
Erasca, Inc.
IPO Date: July 16, 2021
Sector: Healthcare
Industry: Biotech
Market Cap: $6.77B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.27 | 4.20%
Avg Daily Range (30 D): $0.66 | 3.97%
Avg Daily Range (90 D): $0.79 | 5.07%
Institutional Daily Volume
Avg Daily Volume: 1.47M
Avg Daily Volume (30 D): 4.56M
Avg Daily Volume (90 D): 5.69M
Trade Size
Avg Trade Size (Sh.): 131
Avg Trade Size (Sh.) (30 D): 99
Avg Trade Size (Sh.) (90 D): 109
Institutional Trades
Total Institutional Trades: 1,359
Avg Institutional Trade: $2.46M
Avg Institutional Trade (30 D): $3.98M
Avg Institutional Trade (90 D): $2.97M
Avg Institutional Trade Volume: .28M
Avg Institutional Trades (Per Day): 3
Market Closing Trades
Avg Closing Trade: $5.47M
Avg Closing Trade (30 D): $15.08M
Avg Closing Trade (90 D): $10.96M
Avg Closing Volume: 589.05K
 
News
Jul 20, 2026 @ 5:53 PM
ERAS Investors Have Opportunity to Lead Erasca, In...
Source: The Schall Law Firm
Jul 18, 2026 @ 11:56 PM
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Era...
Source: Rosen Law Firm
Jul 15, 2026 @ 4:52 PM
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages E...
Source: Rosen Law Firm
Jul 15, 2026 @ 2:42 AM
Erasca, Inc. Notice of August 10, 2026 Application...
Source: Kahn Swick & Foti, Llc
Jul 14, 2026 @ 1:56 PM
SueWallSt Reminds Shareholders of a Lead Plaintiff...
Source: Suewallst
Financials
  TTM Q4 2025 FY 2025
Basic EPS $-.6 $-.1 $-.44
Diluted EPS $-.6 $-.1 $-.44
Revenue $M $M $M
Gross Profit
Net Income / Loss $-183.44M $-29.09M $-124.55M
Operating Income / Loss $-187.91M $-32.6M $-140.91M
Cost of Revenue
Net Cash Flow $-26.55M $3.58M $6.07M
PE Ratio